J Clin Exp Cardiolog 3:7 Barisic I, Balenovic D, Klicek R, Radic B, Nikitovic B, Drmic D, et al (2013) Mortal hyperkalemia disturbances in rats are NO-system related
GLP-1-based therapies, such as GLP-1 receptor agonists, glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, and dipeptidyl peptidase 4 (DPP-4) inhibitors, improve glucose control through various mechanisms including increased insulin secretion, slower gastric emptying, and reduced postprandial glucagon and food intake
The FDA approves brand medications through a New Drug Application (NDA) process that involves large-scale clinical trials and manufacturing audits
Without enough vitamin B12, homocysteine can build up
Apply heat to stiff joints and tight muscles, and use cold on inflamed areas